Antihypertensive not used in the management of PIH is:
**Core Concept**
Pregnancy-induced hypertension (PIH), also known as gestational hypertension, is a condition characterized by new-onset hypertension after 20 weeks of gestation. Managing PIH requires careful selection of antihypertensive medications to ensure the safety of both the mother and the fetus.
**Why the Correct Answer is Right**
The primary goal in managing PIH is to control blood pressure while minimizing the risk of maternal and fetal complications. Certain antihypertensive medications are contraindicated in PIH due to their potential effects on fetal development or maternal well-being. For instance, **methyldopa** is often used in pregnancy due to its long history of safe use, but other medications like **methylsergide** can cause vasoconstriction, which is undesirable in PIH.
**Why Each Wrong Option is Incorrect**
**Option A:** Methyldopa is actually used in the management of PIH due to its safety profile in pregnancy.
**Option B:** There isn't enough information to confirm this option, but one should consider that Hydralazine is often used in acute management of severe hypertension in pregnancy.
**Option C:** Methylsergide is indeed contraindicated in pregnancy due to its potential to cause vasoconstriction and uterine vasoconstriction leading to fetal growth restriction.
**Clinical Pearl / High-Yield Fact**
Methyldopa is a good starting point for managing PIH, but it's essential to monitor fetal well-being and adjust the treatment plan as needed. Regular blood pressure monitoring and ultrasound assessments are crucial in managing PIH.
**Correct Answer: C. Methylsergide.**